Viewing Study NCT03994627


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2025-12-26 @ 4:12 AM
Study NCT ID: NCT03994627
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2024-12-16
First Post: 2019-06-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module